{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:03:42Z","timestamp":1790978622013,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.nbd.2004.05.002","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T17:27:03Z","timestamp":1087579623000},"page":"654-658","source":"Crossref","is-referenced-by-count":132,"title":["Treatment with miglustat reverses the lipid-trafficking defect in Niemann\u2013Pick disease type C"],"prefix":"10.1016","volume":"16","author":[{"given":"Robin H","family":"Lachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"te Vruchte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emyr","family":"Lloyd-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Reinkensmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Sillence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Fernandez-Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry D","family":"Butters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2004.05.002_BIB1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(98)10034-X","article-title":"Broad screening test for sphingolipid-storage diseases","volume":"354","author":"Chen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2004.05.002_BIB2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2004.05.002_BIB3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.nbd.2004.05.002_BIB4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1023\/A:1005650930330","article-title":"Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann\u2013Pick C mice","volume":"23","author":"Erickson","year":"2000","journal-title":"J. Inherited Metab. Dis."},{"key":"10.1016\/j.nbd.2004.05.002_BIB5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0960-9822(03)00531-1","article-title":"Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent","volume":"13","author":"Gondre-Lewis","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2004.05.002_BIB6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1083\/jcb.139.5.1183","article-title":"Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes","volume":"139","author":"Gu","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2004.05.002_BIB7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2004.05.002_BIB8","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2004.05.002_BIB9","first-page":"472","article-title":"Miglustat. Oxford GlycoSciences\/Actelion","volume":"4","author":"Lachmann","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.nbd.2004.05.002_BIB10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.10.3.455","article-title":"Substrate reduction therapy for glycosphingolipid storage disorders","volume":"10","author":"Lachmann","year":"2001","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.nbd.2004.05.002_BIB11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1034\/j.1600-0854.2000.010304.x","article-title":"Niemann\u2013Pick type C mutations cause lipid traffic jam","volume":"1","author":"Liscum","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.nbd.2004.05.002_BIB12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann\u2013Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2004.05.002_BIB13","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/emboj\/cdg321","article-title":"Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells","volume":"22","author":"Mayran","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2004.05.002_BIB14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/abio.2000.4678","article-title":"High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples","volume":"284","author":"Mellor","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2004.05.002_BIB15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.43.1_Part_1.61","article-title":"The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann\u2013Pick disease type C","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2004.05.002_BIB16","series-title":"The Metabolic and Molecular Bases of Inherited Disease, vol. III","first-page":"3611","article-title":"Niemann\u2013Pick disease type C: a lipid trafficking disorder","author":"Patterson","year":"2001"},{"key":"10.1016\/j.nbd.2004.05.002_BIB17","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2004.05.002_BIB18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay\u2013Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2004.05.002_BIB19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/14084","article-title":"Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases","volume":"1","author":"Puri","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2004.05.002_BIB20","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M300304200","article-title":"Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage","volume":"278","author":"Puri","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2004.05.002_BIB21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1194\/jlr.M200232-JLR200","article-title":"Glucosylceramide modulates membrane traffic along the endocytic pathway","volume":"43","author":"Sillence","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2004.05.002_BIB22","article-title":"Accumulation of glycosphingolipids in Niemann\u2013Pick C disease disrupts endosomal transport","author":"te Vruchte","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2004.05.002_BIB23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","article-title":"Niemann\u2013Pick disease type C","volume":"64","author":"Vanier","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2004.05.002_BIB24","series-title":"Lysosomal Disorders of the Brain","first-page":"290","article-title":"Pathogenic cascades and brain dysfunction","author":"Walkley","year":"2004"},{"key":"10.1016\/j.nbd.2004.05.002_BIB25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jnen\/60.1.49","article-title":"Neurons in Niemann\u2013Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations","volume":"60","author":"Zervas","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2004.05.002_BIB26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann\u2013Pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr. Biol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996104001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996104001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T14:07:26Z","timestamp":1624457246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996104001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0969996104001111"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2004.05.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}